China leads BCI regulation with Neuracle's NEO, facing competition from domestic and international rivals

China has taken an early lead in regulating brain-computer interfaces (BCIs) with the registration of Neuracle's NEO, the first invasive BCI to receive a certificate. This regulatory milestone, however, does not signify a dominant technology, as three distinct Chinese BCI approaches are now competing with established players like Neuralink and Synchron. AI

IMPACT China's regulatory framework for BCIs could accelerate global development and adoption of brain-computer interface technologies.

RANK_REASON Regulatory approval of a novel technology by a major country. [lever_c_demoted from significant: ic=1 ai=0.7]

Read on Pandaily →

• Beijing
• brain–computer interface
• China
• China Medical Device Regulatory
• Chinese Academy of Sciences
• Guangdong
• Neuracle
• Neuralink
• Neuroxena
• Peking Union Medical College
• Shanghai
• Synchron

• policy
• product

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →